Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Hirashima

Showing results (51-60 of 84) with videos related to

Pageof 9
Sort By:
Japanese Journal of Cancer Research : Gann|April 1, 1995
Relationship between the pharmacokinetics of irinotecan and diarrhea during combination chemotherapy with cisplatinS Kudoh, M Fukuoka, N Masuda, et al.
Nihon Kyobu Shikkan Gakkai Zasshi|January 1, 1993
[A case of multiple broncholithiasis caused by mucus retention]T Hirashima, M Tamanoi, S Kojima, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1994
Phase I and pharmacologic study of irinotecan and etoposide with recombinant human granulocyte colony-stimulating factor support for advanced lung cancerN Masuda, M Fukuoka, S Kudoh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
p21 expression as a predictor for favorable prognosis in squamous cell carcinoma of the lungT Komiya, Y Hosono, T Hirashima, et al.
Anticancer Research|January 19, 1999
Prognostic significance of CYFRA 21-1 in non-small cell lung cancerT Hirashima, M Takada, T Komiya, et al.
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|November 1, 1992
[Post operative upper gastrointestinal bleeding in the aged]M Yoshida, T Takahashi, H Hashimoto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Phase I study of irinotecan and cisplatin with granulocyte colony-stimulating factor support for advanced non-small-cell lung cancerN Masuda, M Fukuoka, S Kudoh, et al.
British Journal of Cancer|October 31, 2013
CYP2C19 genotype-based phase I studies of a c-Met inhibitor tivantinib in combination with erlotinib, in advanced/metastatic non-small cell lung cancerN Yamamoto, H Murakami, H Hayashi, et al.
Anticancer Research|January 15, 1998
Prognostic significance of serum p53 antibodies in squamous cell carcinoma of the lungT Komiya, T Hirashima, M Takada, et al.
Surgery, Gynecology & Obstetrics|July 1, 1980
Transabdominal esophageal mucosal transection for the control of esophageal varicesT Hirashima, T Hara, H Takeuchi, et al.
Pageof 9

Showing results (51-60 of 84) with videos related to

Sort By:
Pageof 9
Japanese Journal of Cancer Research : Gann|April 1, 1995
Relationship between the pharmacokinetics of irinotecan and diarrhea during combination chemotherapy with cisplatinS Kudoh, M Fukuoka, N Masuda, et al.
Nihon Kyobu Shikkan Gakkai Zasshi|January 1, 1993
[A case of multiple broncholithiasis caused by mucus retention]T Hirashima, M Tamanoi, S Kojima, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1994
Phase I and pharmacologic study of irinotecan and etoposide with recombinant human granulocyte colony-stimulating factor support for advanced lung cancerN Masuda, M Fukuoka, S Kudoh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
p21 expression as a predictor for favorable prognosis in squamous cell carcinoma of the lungT Komiya, Y Hosono, T Hirashima, et al.
Anticancer Research|January 19, 1999
Prognostic significance of CYFRA 21-1 in non-small cell lung cancerT Hirashima, M Takada, T Komiya, et al.
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|November 1, 1992
[Post operative upper gastrointestinal bleeding in the aged]M Yoshida, T Takahashi, H Hashimoto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Phase I study of irinotecan and cisplatin with granulocyte colony-stimulating factor support for advanced non-small-cell lung cancerN Masuda, M Fukuoka, S Kudoh, et al.
British Journal of Cancer|October 31, 2013
CYP2C19 genotype-based phase I studies of a c-Met inhibitor tivantinib in combination with erlotinib, in advanced/metastatic non-small cell lung cancerN Yamamoto, H Murakami, H Hayashi, et al.
Anticancer Research|January 15, 1998
Prognostic significance of serum p53 antibodies in squamous cell carcinoma of the lungT Komiya, T Hirashima, M Takada, et al.
Surgery, Gynecology & Obstetrics|July 1, 1980
Transabdominal esophageal mucosal transection for the control of esophageal varicesT Hirashima, T Hara, H Takeuchi, et al.
Pageof 9